Press releases

Meet the story of Felipe! One of the dogs participating in the clinical trial

20% of adult dogs may suffer from chronic pain

Vaccine against pain in dogs

First chronic pain vaccine is developed by Xeptiva Therapeutics

Uruguayan researchers and veterinarians are seeking to test the first vaccine against chronic pain in dogs

A team of professionals created a biotechnology venture that developed an innovative treatment for dogs

Uruguayan scientists develop the first vaccine for chronic pain in dogs

Uruguayan biotech startup develops vaccines to reliev chronic pain in companion animals

Vaccine who treats chronic pain in dogs

Xeptiva contributes to the growth of the Uruguayan scientific ecosystem

Scientists develop a vaccine for chronic pain in companion animals

Vaccine against chronic pain in animals

Uruguayan scientists developed a vaccine from synthetically designed proteins

Vaccine for chronic pain in companion animals shows promise in early trials

Uruguayan scientists developed the first vaccine for chronic pain in dogs and cats

Xeptiva moves closer to first vaccine for chronic pain in companion animals

Everything about Xeptiva Therapeutics

Josefina Correa (CEO) and Emiliano Trias (CSO) discussed about the biotech ecosystem in Uruguay and Xeptiva's technology

Veterinary School in Uruguay is looking for dogs with chronic pain for an experimental vaccine study.

Uruguayan scientists develop vaccine for chronic pain

Vaccines to alleviate chronic pain in pets

The Institut Pasteur and the start-up Xeptiva Therapeutics have developed a vaccine to treat pain in pets

Sergio Fogel will invest millions in a company run by two young Uruguayans

Entrepreneurships with sustainable DNA, four young people who opted for triple impact

Time to become an investment magnet

A Uruguayan start-up advances in therapy to block pain in dogs, cats and horses